SLC2A3 and glioblastoma: The ATF4/DDIT4 signal is associated with the dryness of GBM autophagy and SLC2A3 regulation, TMZ resistance and poor prognosis in GBM patients, and the targeted DDIT4/SLC2A3 signal may be the new direction of treatment for GBM [35].